Patents by Inventor Mary Sheridan

Mary Sheridan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INTERNET SYSTEM AND METHOD WITH PREDICTIVE MODELING
    Publication number: 20180232751
    Abstract: A predictive modeling system having a marketability service module and a career path module. The marketability service module of the system server employs a marketability algorithm to determine how marketable a user is based on self-reported work experience and skills for a job. The career path module employs a career path algorithm to provide to the user a prediction of a most successful path from a users current position to a destination position on the basis of a career paths database of transitions provided by a career path analyzer of a batch computing platform intermittently in communication with the career paths database.
    Type: Application
    Filed: February 14, 2018
    Publication date: August 16, 2018
    Inventors: Terrence G. Terhark, Kurtis P. Smith, Mary Sheridan, Alexander Kushnir, Christian Williams
  • Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
    Patent number: 9616037
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: April 11, 2017
    Assignee: PIMCO 2664 Limited
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van't Hof
  • Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
    Publication number: 20160206578
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Application
    Filed: March 21, 2016
    Publication date: July 21, 2016
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van't Hof
  • Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
    Patent number: 9302984
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: April 5, 2016
    Assignee: PIMCO 2664 LIMITED
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
    Publication number: 20150266815
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Application
    Filed: May 22, 2015
    Publication date: September 24, 2015
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
    Patent number: 9050329
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: June 9, 2015
    Assignee: PIMCO 2664 Limited
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
    Publication number: 20150141472
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Application
    Filed: August 21, 2014
    Publication date: May 21, 2015
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
    Patent number: 8822507
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Grant
    Filed: May 3, 2013
    Date of Patent: September 2, 2014
    Assignee: PIMCO 2664 Limited
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
    Publication number: 20130245018
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Application
    Filed: May 3, 2013
    Publication date: September 19, 2013
    Applicant: PIMCO 2664 LIMITED
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use
    Patent number: 8435968
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: May 7, 2013
    Assignee: PIMCO 2664 Limited
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-phenyl-sulfonamide-phenylene compounds and their use
    Patent number: 8207167
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”).
    Type: Grant
    Filed: September 18, 2009
    Date of Patent: June 26, 2012
    Assignee: PIMCO 2664 Limited
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • 39-desmethoxy derivatives of rapamycin
    Patent number: 8008318
    Abstract: The present invention relates to 39-desmethoxyrapamycin derivatives and their uses thereof. The present invention provides for the use of these compounds in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: August 30, 2011
    Assignee: Biotica Technology Limited
    Inventors: Christoph Hendrik Beckmann, Steven James Moss, Rose Mary Sheridan, Mingqiang Zhang, Barrie Wilkinson
  • Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use
    Publication number: 20110190302
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”).
    Type: Application
    Filed: September 18, 2009
    Publication date: August 4, 2011
    Applicant: PIMCO 2664 LIMITED
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use
    Publication number: 20110172189
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
    Type: Application
    Filed: September 18, 2009
    Publication date: July 14, 2011
    Applicant: PIMCO 2664 LIMITED
    Inventors: Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
  • 39-desmethoxy-39-methyl derivatives of rapamycin
    Patent number: 7897608
    Abstract: The present invention relates to novel 39-desmethoxy-39-methylrapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 39-desmethoxy-39 -methylrapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: March 1, 2011
    Assignee: Biotica Technology Limited
    Inventors: Barrie Wilkinson, Mingqiang Zhang, Rose Mary Sheridan
  • 39-Desmethoxy Derivatives of Rapamycin
    Publication number: 20100081682
    Abstract: The present invention relates to 39-desmethoxyrapamycin derivatives and their uses thereof. The present invention provides for the use of these compounds in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Application
    Filed: December 3, 2009
    Publication date: April 1, 2010
    Applicant: Biotica Technology Limited
    Inventors: Christoph Hendrik Beckmann, Steven James Moss, Rose Mary Sheridan, Mingqiang Zhang, Barrie Wilkinson
  • MEDICAL USES OF 39-DESMETHOXYRAPAMYCIN AND ANALOGUES THEREOF
    Publication number: 20100061994
    Abstract: The present invention relates to medical uses of 39-desmethoxyrapamycin analogues.
    Type: Application
    Filed: March 10, 2006
    Publication date: March 11, 2010
    Inventors: Rose Mary Sheridan, Mingqiang Zhang, Matthew Alan Gregory
  • 39-desmethoxyrapamycin, compositions and methods of use thereof
    Patent number: 7655673
    Abstract: The present invention relates to medical uses of 39-desmethoxyrapamycin.
    Type: Grant
    Filed: January 10, 2007
    Date of Patent: February 2, 2010
    Assignee: Biotica Technology Limited
    Inventors: Mingqiang Zhang, Rose Mary Sheridan
  • 39-desmethoxy derivatives of rapamycin
    Patent number: 7648996
    Abstract: The present invention relates to novel 39-desmethoxyrapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 39-desmethoxyrapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: January 19, 2010
    Assignee: Biotica Technology Limited
    Inventors: Christoph Hendrik Beckmann, Steven James Moss, Rose Mary Sheridan, Mingqiang Zhang, Barrie Wilkinson
  • 36-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other Disorders
    Publication number: 20090209572
    Abstract: The present invention relates to novel 36-des(3-methoxy-4-hydroxycyclohexyl)-36-(3-hydroxycycloheptyl)rapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 36-des(3-methoxy-4-hydroxycyclohexyl)-36-(3-hydroxycycloheptyl)rapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Application
    Filed: November 19, 2008
    Publication date: August 20, 2009
    Applicant: Biotica Technology Limited
    Inventors: Barrie Wilkinson, Ming-Qiang Zhang, Rose Mary Sheridan, Christoph Beckmann